Solid Biosciences is considered a speculative buy due to its unique SGT-003 gene therapy for Duchenne muscular dystrophy and a strong cash position expected to last until mid-2028. The company's strategy focuses on proving both biological and functional benefits to satisfy doctors and regulators, aiming to stand out from competitors Sarepta and Regenxbio. Success depends on demonstrating clear advantages in treatment function, safety, and patient eligibility amid competition. While not traditionally cheap, the investment appeal lies in development quality and potential regulatory and commercial milestones rather than market valuation multiples.
Solid Biosciences and its gene therapy focus provide context for Pluang's health sector snapshot as of Sep 25, 2026 14:41 WIB: Among 100 priced health-sector US stocks, 39 rose and 56 fell. Notably, HRTX trades at USD 0.30 with a 3.45% gain and a typical hold time of 34 days, contrasting with TMDX at USD 84.00, which dropped 3.45% despite 100% buy order activity and a shorter hold time of 23 days. Meanwhile, HCA stands at USD 422.89, down 3.11%, held typically for 75 days with full buy order activity, showing a wide price and investor behavior range within the sector.
Ethena has integrated tokenized U.S. equities (Binance bStocks) and equity perpetual futures into its USDe stablecoin backing strategy, moving beyond crypto-only assets. This delta neutral basis trading approach pairs tokenized stock exposure with pe...
U.S. spot Bitcoin ETFs saw combined net inflows of about $2.49 billion from Sept. 17 to Sept. 24, indicating strong demand despite ongoing profit-taking by Bitcoin holders during the recent price rally. Bitcoin traded around $85,000 to $87,000 during...
NVIDIA reported $96.22B revenue in Q2 FY27, up 105.8% YoY, driven by its Vera Rubin platform, which is ramping faster than any prior product and expected to contribute 20% of data center revenue in Q3. AMD posted $11.54B, up 50.1% YoY, with its Helio...
Quant (QNT) surged 40% on September 25 following a key partnership with The Clearing House to support its On-Chain Money Initiative, a major U.S. tokenized deposit network project. This partnership is significant as The Clearing House processes over ...
The TRON blockchain network has exceeded $30 trillion in cumulative transfer volume as of September 23, 2026, highlighting its significant role in stablecoin payments and settlements. The network hosts over 405 million accounts and has processed 15.6...
